Status:
RECRUITING
A Multi-center Study on Artificial Intelligence-Based Quantitative Evaluation of Echocardiography
Lead Sponsor:
First Hospital of China Medical University
Conditions:
Artificial Intelligence (AI)
Artificial Intelligence (AI) in Diagnosis
Eligibility:
All Genders
18-80 years
Brief Summary
This project aims to collaborate with multiple medical institutions to verify the accuracy, stability, and clinical application value of AI algorithms in echocardiographic quantitative measurement thr...
Detailed Description
Cardiovascular disease is a major threat to the health of Chinese residents, and echocardiography, as its core diagnostic tool, directly affects clinical decision-making in terms of measurement accura...
Eligibility Criteria
Inclusion
- Age ≥18 - 80 years;
- Types of diseases (8 in total, 200 cases each):
- Normal heart
- Coronary heart disease (with segmental thinning and abnormal movement)
- Valve disease (valve stenosis or reflux)
- Hypertensive heart disease
- Atrial fibrillation
- Heart failure
- Dilated cardiomyopathy
- Hypertrophic cardiomyopathy
Exclusion
- Patients with congenital heart disease
- Patients with poor image quality
Key Trial Info
Start Date :
July 22 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 31 2026
Estimated Enrollment :
1600 Patients enrolled
Trial Details
Trial ID
NCT07133516
Start Date
July 22 2025
End Date
July 31 2026
Last Update
August 21 2025
Active Locations (37)
Enter a location and click search to find clinical trials sorted by distance.
1
Huainan First People's Hospital
Huainan, Anhui, China
2
Union Hospital Affiliated to Fujian Medical University
Fuzhou, Fujian, China
3
Meizhou People's Hospital
Meizhou, Guangdong, China
4
Shantou Central Hospital
Shantou, Guangdong, China